Scottish biotech pioneer set to break ground on ‘peat-free’ production plant The Scotsman 2h Biotechnology Pharma Article paywall
STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d Novartis Pharma Science
STAT Plus: After failure of Angelman syndrome drug, experts see hope in other experimental therapies STAT 3d Pharma
